Data / Form D filings / Sonnet BioTherapeutics Holdings, Inc.
Sonnet BioTherapeutics Holdings, Inc.: Form D filings
Sonnet BioTherapeutics Holdings, Inc., a biotechnology company in Princeton, NJ, filed 12 Form D notices with the SEC between 2011 and 2024. The latest, on December 23, 2024, reports $3.9 million sold of a $3.9 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 100 OVERLOOK CETNER, SUITE 102, Princeton, NJ, 08540
- Phone
- (609) 375-2227
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1106838
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 23, 2024 | New notice | $3,918,000 | $3,918,000 | 4 | Dec 10, 2024 | sec.gov | |
| Jul 17, 2023 | New notice | $2,250,000 | $2,250,000 | 1 | Jun 30, 2023 | sec.gov | |
| Aug 19, 2022 | New notice | $2,250,000 | $2,250,000 | 5 | Aug 15, 2022 | sec.gov | |
| May 16, 2018 | New notice | $1,411,249 | $1,411,249 | 13 | May 3, 2018 | sec.gov | |
| May 11, 2017 | New notice | $6,000,000 | $6,000,000 | 14 | May 4, 2017 | sec.gov | |
| Mar 18, 2015 | New notice | $1,000,000 | $1,000,000 | 1 | Mar 13, 2015 | sec.gov | |
| Jan 16, 2015 | New notice | $1,150,000 | $1,150,000 | 12 | Jan 2, 2015 | sec.gov | |
| Nov 20, 2013 | New notice | $800,000 | $800,000 | 3 | Nov 7, 2013 | sec.gov | |
| Oct 22, 2013 | New notice | $2,500,000 | $2,500,000 | 23 | Oct 7, 2013 | sec.gov | |
| Oct 15, 2013 | New notice | Indefinite | $0 | 193 | Sep 30, 2013 | sec.gov | |
| Aug 13, 2013 | New notice | $3,000,000 | $3,000,000 | 7 | Aug 2, 2013 | sec.gov | |
| Nov 30, 2011 | New notice | $1,125,000 | $1,125,000 | 7 | Jul 22, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John K. Cini | Executive Officer | |
| Albert K. Dyrness | Director | |
| Nailesh K. Bhatt | Director | |
| Pankaj Mohan | Executive Officer, Director | |
| Donald K. Griffith | Director | |
| Susan K. Dexter | Executive Officer | |
| Richard K. Kenny | Executive Officer | |
| Raghu K. Rao | Director | |
| Jay Cross | Executive Officer | |
| Lori K. McNeil | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
- Bullseye Biodevices, Inc. $1.3 million · Aug 10, 2026
- Hepion Pharmaceuticals, Inc. $3.1 million · Aug 5, 2026
Every Form D from the week of Dec 23, 2024 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sonnet BioTherapeutics Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.